#66 Seasoned Biotech Executive talks T-Cell Therapy and Running a Business in 2023!

On this episode of BioTech IQ, Ammon interviews Paul Lammers the CEO of Triumvira about developing autologus cell therapies using their T-Cell Antigen Coupler Platform (TAC). During this insightful discussion Paul talks about how he started in the industry, running a biotech company in today's environment, and what sets Triumvira's T-Cell therapy apart from the rest! Don't miss it!Show support for show https://www.buymeacoffee.com/biotechiqCheck out the books recommended by Paul:CEO Excellence - https://amzn.to/3OGjI3GThe Emperor of All Maladies - https://amzn.to/3IDyZ1lSupport the showCheck me out on LinkedIn https://www.linkedin.com/in/ammonr/

Om Podcasten

Increase your IQ and understanding of the Biotech industry by listening to interviews with key business leaders who have built successful companies and departments. We discuss everything from the science, clinical operations, clinical development, safety/PV and more! We address how each function plays an important role in the drug approval process. We also discuss the people that make up these departments. Get ready to hear about cutting edge development and the people who make it happen!